CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-03 | Leuthner Brian A President and CEO | Sale | −2,500 | $10.27 | $26K | 132,736 |
| 2017-06-20 | BARER SOL J Director | Grant or award · Stock Option (right To Purchase) | +30,000 | $10.15 | $305K | 30,000 |
| 2017-06-20 | BLECH ISAAC Director | Grant or award · Stock Option (right To Purchase) | +15,000 | $10.15 | $152K | 15,000 |
| 2017-06-20 | Conti Kurt G Director | Grant or award · Stock Option (right To Purchase) | +15,000 | $10.15 | $152K | 15,000 |
| 2017-06-20 | HEALY JAMES Director | Grant or award · Stock Option (right To Purchase) | +15,000 | $10.15 | $152K | 15,000 |
| 2017-06-20 | LOUGHLIN JAMES J Director | Grant or award · Stock Option (right To Purchase) | +15,000 | $10.15 | $152K | 15,000 |
| 2017-06-20 | Ratcliffe Liam Director | Grant or award · Stock Option (right To Purchase) | +15,000 | $10.15 | $152K | 15,000 |
| 2017-06-20 | Spiegel Robert J. Director | Grant or award · Stock Option (right To Purchase) | +15,000 | $10.15 | $152K | 15,000 |
| 2017-04-26 | Leuthner Brian A President and CEO | Sale | −100 | $11.10 | $1K | 135,236 |
| 2017-03-13 | MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary | Grant or award · Stock Option (right To Purchase) | +52,500 | $8.86 | $465K | 52,500 |
| 2017-03-13 | Macdonald R. Loch Chief Scientific Officer | Grant or award · Stock Option (right To Purchase) | +110,000 | $8.86 | $975K | 110,000 |
| 2017-03-13 | MARCHIO ALBERT N II Chief Accounting & Ops Officer | Grant or award · Stock Option (right To Purchase) | +47,500 | $8.86 | $421K | 47,500 |
| 2017-03-13 | Leuthner Brian A President and CEO | Grant or award · Stock Option (right To Purchase) | +267,500 | $8.86 | $2.4M | 267,500 |
| 2017-03-13 | Faleck Herbert J Chief Medical Officer | Grant or award · Stock Option (right To Purchase) | +110,000 | $8.86 | $975K | 110,000 |
| 2017-03-13 | Yaman Alpaslan V.P., Technical Ops. & Mfg. | Grant or award · Stock Option (right To Purchase) | +40,000 | $8.86 | $354K | 40,000 |
| 2017-03-06 | LOUGHLIN JAMES J Director | Purchase | +3,000 | $9.24 | $28K | 6,000 |
| 2017-03-01 | Einhorn Andrew J. Chief Financial Officer | Option exercise | +1,567 | $2.39 | $4K | 43,223 |
| 2017-03-01 | Einhorn Andrew J. Chief Financial Officer | Option exercise · Warrants (right To Purchase) | −1,567 | 0 | ||
| 2017-03-01 | Wyant Alyssa SVP Regulatory Affairs | Grant or award · Stock Option (right To Purchase) | +80,000 | $9.81 | $785K | 80,000 |
| 2017-02-07 | Leuthner Brian A President and CEO | Sale | −1,500 | $9.52 | $14K | 245,479 |
Page 12 of 18 · 346 trades